NPS Pharma (NPSP) Misses Q4 EPS by 8c

Go back to NPS Pharma (NPSP) Misses Q4 EPS by 8c

Form 10-K NPS PHARMACEUTICALS INC For: Dec 31

February 18, 2015 4:17 PM EST

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

       x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2014

Commission File Number 0-23272

NPS PHARMACEUTICALS, INC.
(Exact... More